Phase 1/2 dose-escalation and expansion study investigating SAR439859+/- palbociclib in postmenopausal women with estrogen receptor-positive (ER+)/HER2- metastatic breast cancer Meeting Abstract

  

Authors:	Bardia, A.; Linden, H. M.; Ulaner, G. A.; Chandarlapaty, S.; Gosselin, A.; Celanovic, M.; Campone, M.
Abstract Title:	Phase 1/2 dose-escalation and expansion study investigating SAR439859+/- palbociclib in postmenopausal women with estrogen receptor-positive (ER+)/HER2- metastatic breast cancer
Meeting Title:	55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	37
Issue:	15 Suppl.
Meeting Dates:	2019 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2019-05-20
Start Page:	60s
Language:	English
ACCESSION:	WOS:000487345803225
DOI:	10.1200/JCO.2019.37.15_suppl.TPS1105
PROVIDER:	wos
Notes:	Meeting Abstract: TPS1105 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/156226